1.Current status of eating behaviors and its predictive role in overweight and obese of adolescents
Chinese Journal of School Health 2025;46(1):53-57
Objective:
To explore the current status and influencing factors of eating behaviors in adolescents, so as to provide a theoretical foundation for health promotion education among adolescents.
Methods:
Based on the database from Survey of Chinese Family Health Index (2021), by a random number table method, 1 065 teenagers were selected from the provincial capitals of 22 provinces and 5 autonomous regions in China, as well as 4 municipalities directly under the central government. A general characteristic questionnaire, Patient Health Questionnaire-9 (PHQ-9), Short Form of the Family Health Scale (FHS-SF), 10-item Short Version of the Big Five Personality(BFP-10), Content-based Media Exposure Scale (CM-E) and Sakata Eating Behavior Scale Short Form(EBS-SF) were used to collect information. Multivariate stepwise linear regression analysis was employed to identify and analyze related factors of eating behaviors among adolescents. Receiver operating characteristic was used to validate the predictive ability of the EBS-SF score for overweight and obesity among adolescents.
Results:
The average scores of BFI-10,C-ME, FHS-SF, PHQ-9 and EBS-SF were (33.08±4.64)(19.20±4.55)(38.48±6.65)(6.09±5.63)(16.75±4.36), respectively. Multivariate linear regression showed that family type (other types), agreeableness, conscientiousness, family health and depression were the main related factors of EBS-SF scores among adolescents( B =2.61,-0.42,0.20,-0.11,0.23, P <0.05).The analysis of receiver operating characteristic curve showed that the EBS-SF scores had a good ability in predicting obesity among male adolescents ( AUC= 0.73, P <0.01).
Conclusions
Family type, big five personality, family health,depression are the related factors of eating behaviors among adolescents. EBS-SF scores are predictive of obesity in adolescents, which would provide a new perspective for promoting healthy eating habits among adolescents.
2.Effect of polystyrene microplastics combined with high-fat treatment on vascular endothelial cells
Jing WANG ; Jiani DIAO ; Jing LONG ; Yuguang HE ; Lipin TAN ; Xuemei CHEN ; Fangfang LI ; Junlin HE ; Yingxiong WANG ; Rufei GAO ; Weike LI
Journal of Chongqing Medical University 2025;50(7):969-976
Objective:To investigate the effect of polystyrene microplastics(PS-MPs)combined with high-fat treatment on vascular endothelial cells.Methods:Human umbilical vein endothelial cells(HUVECs)were cultured in the DMEM medium containing 5%fe-tal bovine serum.HUVECs were treated with conventional culture,high-fat treatment,and PS-MPs combined with high-fat treatment.The experiment was conducted in the three groups of control group,high-fat treatment group and PS-MPs+high-fat treatment group.CCK-8 assay was used to measure cell viability,F-actin staining was used to observe cell morphological changes,and flow cytometry,scratch assay,and tube formation assay were used to measure the apoptosis,migration,and tube-forming ability of cells.Results:After HUVECs were exposed to the high-fat environment,there was a significant reduction in cell viability,shrinkage of cells,a signifi-cant increase in cell apoptosis,and significant reductions in cell migration and tube-forming ability.Compared with the high-fat treat-ment group,there were no significant changes in cell viability,cell morphology,cell apoptosis,and cell migration ability after PS-MPs combined with high-fat treatment,but the tube-forming ability of cells was further impaired.Conclusion:High-fat treatment will affect cell viability,change cell morphology,and damage vascular endothelial cell function,and PS-MPs combined with high-fat treat-ment can aggravate the damage of vascular endothelial cell function.
3.Interpretation of the 2024 European guidelines on the diagnosis and management of pediatric eosinophilic esophagitis
Weimei HE ; Chenmei ZHANG ; Jiani SHAN
Chinese Journal of Digestion 2025;45(3):145-155
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease driven by immune mechanisms, characterized by abnormal eosinophilic infiltration of the esophageal epithelium. EoE′s pathogenesis is closely associated with food allergens, and clinical manifestations primarily include dysphagia, food impaction, and children patients may also have growth restriction. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition first published guidelines for the management of pediatric EoE in 2014. With increasing understanding of the disease mechanisms and treatment responses, the 2024 guidelines have comprehensively updated the diagnostic and therapeutic strategies.This paper provides a systematic interpretation of the 2024 guidelines, focusing on the revised diagnostic criteria, optimization of dietary therapy, and improved management strategies for esophageal strictures. Furthermore, a comparison of the 2014 and 2024 guidelines highlights significant advancements in EoE management over the past decade and their implications for clinical practice.
4.Interpretation of the 2024 European guidelines on the diagnosis and management of pediatric eosinophilic esophagitis
Weimei HE ; Chenmei ZHANG ; Jiani SHAN
Chinese Journal of Digestion 2025;45(3):145-155
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease driven by immune mechanisms, characterized by abnormal eosinophilic infiltration of the esophageal epithelium. EoE′s pathogenesis is closely associated with food allergens, and clinical manifestations primarily include dysphagia, food impaction, and children patients may also have growth restriction. The European Society for Paediatric Gastroenterology, Hepatology, and Nutrition first published guidelines for the management of pediatric EoE in 2014. With increasing understanding of the disease mechanisms and treatment responses, the 2024 guidelines have comprehensively updated the diagnostic and therapeutic strategies.This paper provides a systematic interpretation of the 2024 guidelines, focusing on the revised diagnostic criteria, optimization of dietary therapy, and improved management strategies for esophageal strictures. Furthermore, a comparison of the 2014 and 2024 guidelines highlights significant advancements in EoE management over the past decade and their implications for clinical practice.
5.Visual analysis of hotspots and frontiers on artificial intelligence in nursing in China
Jiani YAO ; Shihua CAO ; Xiajing LOU ; Bingsheng WANG ; Yankai SHI ; Danni HE ; Yanfei CHEN
Chinese Journal of Modern Nursing 2024;30(25):3431-3438
Objective:To explore the research status of artificial intelligence in nursing in China, so as to provide reference for conducting research domestically.Methods:The relevant literature collected from January 1, 2003 to May 1, 2023 was searched on China National Knowledge Infrastructure, WanFang Data, and VIP. CiteSpace and VOS viewer were used to visually analyze the research status, hotspots, and frontiers of artificial intelligence in nursing in China from the aspects of annual publication volume, region, institution, author, high-frequency keywords, and emerging words.Results:A total of 494 articles were included. In terms of publication volume, domestic research showed an overall upward trend, with publishing institutions mostly concentrated in economically developed and medically advanced regions. The authors of the articles often collaborated with research groups, with a co-authorship rate of 81.17% (401/494), but there was relatively little collaboration between groups. Research hotspots were focused on the application of artificial intelligence in geriatric nursing, rehabilitation nursing, Operating Rooms, and drug formulation, with a majority of research related to robots.Conclusions:The research enthusiasm in related fields in China is currently on the rise. Research on artificial intelligence in nursing management, nursing education, and psychological nursing can be strengthened, and the application of artificial intelligence can be enriched. At the same time, research institutions and personnel should strengthen mutual cooperation, and relevant national departments should improve laws and regulations to promote the vigorous development of this research field.
6.Clinical Experience Applying the "Kidney-supplementing and Blood-invigorating" Method to Treat Infertility of Repeated Implantation Failure
Kun MA ; Guanlan ZHONG ; Han ZHANG ; Dandan HE ; Jiani LI ; Qian LI ; Shanfeng GAO
Journal of Traditional Chinese Medicine 2024;65(24):2593-2597
kidney deficiency and blood stasis are believed to be the key pathogenesis of recurrent implantation failure (RIF), and therefore, it is proposed to take kidney-supplementing and blood-invigorating as the basic treatment method, and use it by stages to assist the controlled superovulation program of in vitro fertilization-embryo transfer (IVF-ET). The focus should be put on nourishing kidney yin, soothing the liver and invigorating blood during down-regulation period, using kidney yin-nourishing medicinals and modified Qinghao Biejia Decoction (青蒿鳖甲汤). During the ovulation induction period, the focus should be put on nourishing kidney yang, replenishing blood, and promoting blood circulation, with self-made Bushen Culuan Formula (补肾促卵方) in modifications. After transplantation, it is suggested to put focus on tonifying the kidneys and replenishing essence, and self-made Wuzi Yanzong Guchong Decoction (五子衍宗固冲汤) in modifications can be used. At the same time, fetal protection treatment should be carried out for pregnant women, and modified Shou Tai Pill (寿胎丸) can be used to tonify the kidneys and calm the fetus.
7.Clinical management and surgical techniques for neonates and infants with ebstein anomaly: an interpretation of the 2024 expert consensus from the American Association for Thoracic Surgery
Weimei HE ; Jiani SHAN ; Chenmei ZHANG ; Xiwang LIU
Chinese Journal of Thoracic and Cardiovascular Surgery 2024;40(12):716-727
Currently, there is a lack of localized guidelines or consensus on the management of Ebstein anomaly (EA) in China, particularly concerning the treatment of neonates and infants. The 2024 Expert Consensus issued by the American Association for Thoracic Surgery provides detailed guidance on the clinical management of EA, covering key aspects such as the timing of surgical interventions, selection of surgical techniques, and postoperative management. The interpretation of this consensus is of great significance for thoracic surgeons in China to understand the latest international academic developments and can serve as a valuable reference for clinical practice. The consensus outlines the latest surgical techniques adopted internationally, including the Starnes procedure, biventricular repair, and 1.5 ventricle repair, and provides an in-depth analysis of the optimal timing and strategies for interventions in different cases. This offers a theoretical foundation and technical reference for advancing the field in China, contributing to the standardization and regulation of EA treatment.
8.Diagnosis and treatment of eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis in pediatric: interpretation of joint European and North American guidelines
Weimei HE ; Jiani SHAN ; Chenmei ZHANG
Chinese Journal of Digestion 2024;44(9):577-585
To interpret the clinical practice guidelines for pediatric and eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis (non-EoE EGID), jointly developed by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. The guidelines provide new standards for the diagnosis and treatment of non-EoE EGID. They include detailed explanations on disease classification, diagnostic and therapeutic challenges, guideline development methodology, epidemiology, etiological mechanisms, symptoms, endoscopic and imaging examinations, other tests, differential diagnosis, and treatment strategies. The paper explores the importance of comprehensive assessment in children with non-EoE EGID. Improvement suggestions are proposed, such as developing symptom assessment tools, conducting quality of life impact studies, standardizing eosinophil density reporting, refining diagnostic criteria, and formulating specific treatment guidelines. These measures aim to enhance the diagnostic and therapeutic accuracy for non-EoE EGID and improve the clinical management of affected children.
9.Diagnosis and Treatment of Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis in Pediatrics:Interpretation of Joint European and North American Guidelines
Weimei HE ; Jiani SHAN ; Chenmei ZHANG
Chinese Journal of Gastroenterology 2024;29(11):668-676
To interpret the clinical practice guidelines for pediatric and eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis(non-EoE EGID),jointly developed by the European Society for Paediatric Gastroenterology,Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology,Hepatology and Nutrition.The guidelines provide new standards for the diagnosis and treatment of non-EoE EGID.They include detailed explanations on disease classification,diagnostic and therapeutic challenges,guideline development methodology,epidemiology,etiological mechanisms,symptoms,endoscopic and imaging examinations,other tests,differential diagnosis,and treatment strategies.The paper explores the importance of comprehensive assessment in children with non-EoE EGID.Improvement suggestions are proposed,such as developing symptom assessment tools,conducting quality of life impact studies,standardizing eosinophil density reporting,refining diagnostic criteria,and formulating specific treatment guidelines.These measures aim to enhance the diagnostic and therapeutic accuracy for non-EoE EGID and improve the clinical management of affected children.
10.Diagnosis and Treatment of Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis in Pediatrics:Interpretation of Joint European and North American Guidelines
Weimei HE ; Jiani SHAN ; Chenmei ZHANG
Chinese Journal of Gastroenterology 2024;29(11):668-676
To interpret the clinical practice guidelines for pediatric and eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis(non-EoE EGID),jointly developed by the European Society for Paediatric Gastroenterology,Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology,Hepatology and Nutrition.The guidelines provide new standards for the diagnosis and treatment of non-EoE EGID.They include detailed explanations on disease classification,diagnostic and therapeutic challenges,guideline development methodology,epidemiology,etiological mechanisms,symptoms,endoscopic and imaging examinations,other tests,differential diagnosis,and treatment strategies.The paper explores the importance of comprehensive assessment in children with non-EoE EGID.Improvement suggestions are proposed,such as developing symptom assessment tools,conducting quality of life impact studies,standardizing eosinophil density reporting,refining diagnostic criteria,and formulating specific treatment guidelines.These measures aim to enhance the diagnostic and therapeutic accuracy for non-EoE EGID and improve the clinical management of affected children.


Result Analysis
Print
Save
E-mail